Increased angiotensinogen expression, urinary angiotensinogen excretion, and tissue injury in nonclipped kidneys of two-kidney, one-clip hypertensive rats

American Journal of Physiology - Renal Physiology

Volumn 311, Issue 2, 2016, Pages F278-F290

  Shao, Weijian ^a   Miyata, Kayoko ^a   Katsurada, Akemi ^a   Satou, X Ryousuke ^a   Seth, Dale M ^a   Rosales, Carla B ^a   Prieto, Minolfa C ^a   Mitchell, Kenneth D ^a   Navar, L Gabriel ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glomerular filtration rate; Intrarenal angiotensinogen messenger ribonucleic acid expression; Renal hemodynamics; Renal injury; Renin angiotensin system

Indexed keywords

ANGIOTENSINOGEN; MESSENGER RNA; SODIUM ION; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BODY WEIGHT; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; EVALUATION STUDY; FLUID INTAKE; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PARENCHYMA; KIDNEY PLASMA FLOW; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM EXCRETION; URINARY EXCRETION; URINE VOLUME; ANIMAL; BIOSYNTHESIS; CELLULAR IMMUNITY; DRINKING; FIBROSIS; GENETICS; GLOMERULUS; KIDNEY; KIDNEY MEDULLA; MALE; METABOLISM; PATHOLOGY; RENOVASCULAR HYPERTENSION; SPRAGUE DAWLEY RAT; URINE;

ANGIOTENSINOGEN; ANIMALS; ARTERIAL PRESSURE; BODY WEIGHT; DRINKING; FIBROSIS; HYPERTENSION, RENOVASCULAR; IMMUNITY, CELLULAR; KIDNEY; KIDNEY GLOMERULUS; KIDNEY MEDULLA; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SODIUM;

EID: 84984595776     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00419.2015     Document Type: Article

References (58)

1. Babu CS, Kalaivani P, Ranju V, Sathiya S, Anbarasi C, Mahadevan MV, Vijayakumar H, Sunil AG, Thanikachalam S. Venthamarai chooranam, a polyherbal Siddha medicine, alleviates hypertension via AT1R and eNOS signaling pathway in 2K1C hypertensive rats. Exp Biol Med 239: 758–769, 2014.
2. Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nature reviews Nephrology 6: 643–656, 2010.
3. Cervenka L, Wang CT, Mitchell KD, Navar LG. Proximal tubular angiotensin II levels and renal functional responses to AT 1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats. Hypertension 33: 102–107, 1999.
4. Chade AR. Renal vascular structure and rarefaction. Compr Physiol 3: 817–831, 2013.
5. Clavreul N, Sansilvestri-Morel P, Magard D, Verbeuren TJ, Rupin A. (Pro)renin promotes fibrosis gene expression in HEK cells through a Nox4-dependent mechanism. Am J Physiol Renal Physiol 300: F1310–F1318, 2011.
6. Eirin A, Ebrahimi B, Zhang X, Zhu XY, Tang H, Crane JA, Lerman A, Textor SC, Lerman LO. Changes in glomerular filtration rate after renal revascularization correlate with microvascular hemodynamics and inflammation in Swine renal artery stenosis. Circ Cardiovasc Interv 5: 720–728, 2012.
7. Floege J, Eitner F, Alpers CE. A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 19: 12–23, 2008.
8. Gilbert RE, Zhang Y, Williams SJ, Zammit SC, Stapleton DI, Cox AJ, Krum H, Langham R, Kelly DJ. A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat. PloS one 7: e47160, 2012.
9. Gonzalez-Villalobos RA, Satou R, Ohashi N, Semprun-Prieto LC, Katsurada A, Kim C, Upchurch GM, Prieto MC, Kobori H, Navar LG. Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition. Am J Physiol Renal Physiol 298: F150–F157, 2010.
10. Gonzalez-Villalobos RA, Seth DM, Satou R, Horton H, Ohashi N, Miyata K, Katsurada A, Tran DV, Kobori H, Navar LG. Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice. Am J Physiol Renal Physiol 295: F772–F779, 2008.
11. Graciano ML, Mitchell KD. Imatinib ameliorates renal morphological changes in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension. Am J Physiol Renal Physiol 302: F60–F69, 2012.
12. Graciano ML, Nishiyama A, Jackson K, Seth DM, Ortiz RM, Prieto-Carrasquero MC, Kobori H, Navar LG. Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension. Am J Physiol Renal Physiol 294: F161–F169, 2008.
13. Graciano ML, Nishiyama A, Jackson KE, Seth DM, Navar LG. Purinergic receptor blockade prevents early renal injury during angiotensin II-induced hypertension. J Am Soc Nephrol 16: 2005.
14. Guan S, Fox J, Mitchell KD, Navar LG. Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats. Hypertension 20: 763–767, 1992.
15. Howard CG, Mullins JJ, Mitchell KD. Direct renin inhibition with aliskiren normalizes blood pressure in Cyp1a1-Ren2 transgenic rats with inducible angiotensin II-dependent malignant hypertension. Am J Med Sci 341: 383–387, 2011.
16. Huang J, Siragy HM. Sodium depletion enhances renal expression of (pro)renin receptor via cyclic GMP-protein kinase G signaling pathway. Hypertension 59: 317–323, 2012.
17. Huang WC, Ploth DW, Bell PD, Work J, Navar LG. Bilateral renal function responses to converting enzyme inhibitor (SQ 20881) in two kidney one clip Goldblatt hypertensive rats. Hypertension 3: 285–293, 1981.
18. Huang WC, Ploth DW, Navar LG. Angiotensin mediated alterations in nephron function in Goldblatt hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 243: F553–F560, 1982.
19. Huang WC, Ploth DW, Navar LG. Effects of saralasin infusion on bilateral renal function in 2 kidney, 1 clip Goldblatt hypertensive rats. Clin Sci 62: 573–579, 1982.
20. Ingelfinger J, Zuo WM, Fon EA, Ellison KE, Dzau VJ. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. J Clin Invest 85: 417–423, 1990.
21. Kelsen S, He X, Chade AR. Early superoxide scavenging accelerates renal microvascular rarefaction and damage in the stenotic kidney. Am J Physiol Renal Physiol 303: F576–F583, 2012.
22. Kobori H, Harrison-Bernard LM, Navar LG. Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 12: 431–439, 2001.
23. Kobori H, Harrison-Bernard LM, Navar LG. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 61: 579–585, 2002.
24. Kobori H, Katsurada A, Miyata K, Ohashi N, Satou R, Saito T, Hagiwara Y, Miyashita K, Navar LG. Determination of Plasma and Urinary Angiotensinogen Levels in Rodents by Newly Developed ELISA. Am J Physiol Renal Physiol 294: F1257–F1263, 2008.
25. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251–287, 2007.
26. Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG. Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension. Hypertension 41: 42–49, 2003.
27. Kobori H, Ozawa Y, Suzaki Y, Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol 16: 2073–2080, 2005.
28. Kobori H, Prieto-Carrasquero MC, Ozawa Y, Navar LG. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 43: 1126–1132, 2004.
29. Komlosi P, Fuson AL, Fintha A, Peti-Peterdi J, Rosivall L, Warnock DG, Bell PD. Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport. Hypertension 42: 195–199, 2003.
30. Lara LS, McCormack M, Semprum-Prieto LC, Shenouda S, Majid DS, Kobori H, Navar LG, Prieto MC. AT1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in ANG II-salt hypertension. Am J Physiol Renal Physiol 302: F85–F94, 2012.
31. Masaki Z, Ferrario CM, Bumpus FM. Effects of SQ 20,881 on the intact kidney of dogs with two-kidney, one clip hypertension. Hypertension 2: 649–656, 1980.
32. Mitchell KD, Botros FT, Navar LG. Intrarenal renin-angiotensin system and counteracting protective mechanisms in angiotensin II-dependent hypertension. Acta Physiol Hungarica 94 31–48, 2007.
33. Mitchell KD, Navar LG. Intrarenal actions of angiotensin II in the pathogenesis of experimental hypertension. In: Hypertension: Pathophysiology, Diagnosis, and Management, edited by Laragh JH Brenner BM. New York, NY: Raven, 1995, p. 1437–1450.
34. Miyata K, Ohashi N, Suzaki Y, Katsurada A, Kobori H. Sequential activation of the reactive oxygen species/angiotensinogen/renin-angiotensin system axis in renal injury of type 2 diabetic rats. Clin Exp Pharmacol Physiol 35: 922–927, 2008.
35. Miyata K, Satou R, Inui D, Katsurada A, Seth D, Davis A, Urushihara M, Kobori H, Mitchell KD, Navar LG. Renoprotective effects of direct renin inhibition in glomerulonephritis. Am J Med Sci 348: 306–314, 2014.
36. Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA. Intratubular renin-angiotensin system in hypertension. Hypertension 57: 355–362, 2011.
37. Navar LG, Ploth DW. Pathophysiology of renovascular hypertension. In: Hypertension Primer: The Essentials of High Blood Pressure, edited by Izzo JL, Black HR, Sica DA. Philadelphia, PA: Williams & Wilkins, 2008, p. 162–165.
38. Nikolic-Paterson DJ, Lan HY, Hill PA, Atkins RC. Macrophages in renal injury. Kidney Int Suppl 45: S79–S82, 1994.
39. Ohashi N, Urushihara M, Satou R, Kobori H. Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species–ERK/JNK pathways. Hypertens Res 33: 1174–1181, 2010.
40. Ozawa Y, Kobori H. Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury. Am J Physiol Renal Physiol 293: F100–F109, 2007.
41. Ozawa Y, Kobori H, Suzaki Y, Navar LG. Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol 292: F330–F339, 2007.
42. Ploth DW. Angiotensin-dependent renal mechanisms in two-kidney oneclip renal vascular hypertension. Am J Physiol Renal Fluid Electrolyte Physiol 245: F131–F141, 1983.
43. Polichnowski AJ, Cowley AW Jr. Pressure-induced renal injury in angiotensin II versus norepinephrine-induced hypertensive rats. Hypertension 54: 1269–1277, 2009.
44. Prieto-Carrasquero MC, Botros FT, Pagan J, Kobori H, Seth DM, Casarini DE, Navar LG. Collecting duct renin is upregulated in both kidneys of 2-kidney, 1-clip goldblatt hypertensive rats. Hypertension 51: 1590–1596, 2008.
45. Prieto MC, Gonzalez-Villalobos RA, Botros FT, Martin VL, Pagan J, Sato R, Lara LS, Feng Y, Fernandez F, Kobori H, Casarini DE, Navar LG. Reciprocal changes in renal ACE/Ang II and ACE2/Ang 1–7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats. Am J Physiol Renal Physiol 300: F749–F755, 2011.
46. Rands VF, Seth DM, Kobori H, Prieto MC. Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension. GendMed 9: 207–218, 2012.
47. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167–4171, 1986.
48. Satou R, Gonzalez-Villalobos RA, Miyata K, Ohashi N, Katsurada A, Navar LG, Kobori H. Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells. Am J Physiol Renal Physiol 295: F283–F289, 2008.
49. Satou R, Shao W, Navar LG. Role of stimulated intrarenal angiotensinogen in hypertension. Ther Advan Cardiovas Dis 9: 181–190, 2015.
50. Schwietzer G. Angiotensin II dependency of vascular resistance in the untouched kidney of renal hypertensive rats. Nephron 26: 195–199, 1980.
51. Shao W, Seth DM, Prieto MC, Kobori H, Navar LG. Activation of the renin-angiotensin system by a low-salt diet does not augment intratubular angiotensinogen and angiotensin II in rats. Am J Physiol Renal Physiol 304: F505–F514, 2013.
52. Skogstrand T, Leh S, McClure J, Dashti M, Iversen BM, Graham D, McBride MW, Hultstrom M. Identification of a common molecular pathway in hypertensive renal damage: comparison of rat and human gene expression profiles. J Hypertens 33: 584–596, 2015.
53. Skogstrand T, Leh S, Paliege A, Reed RK, Vikse BE, Bachmann S, Iversen BML, Hultstrom M. Arterial damage precedes the development of interstitial damage in the nonclipped kidney of two-kidney, one-clip hypertensive rats. J Hypertens 31: 152–159, 2013.
54. Steiner RW, Tucker BJ, Gushwa LC, Gifford J, Wilson CB, Blantz RC. Glomerular hemodynamics in moderate Goldblatt hypertension in the rat. Hypertension 4: 51–57, 1982.
55. Terada Y, Tomita K, Nonoguchi H, Marumo F. PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int 43: 1251–1259, 1993.
56. Von Thun AM, El-Dahr SS, Vari RC, Navar LG. Modulation of renin-angiotensin and kallikrein gene expression in experimental hypertension. Hypertension 23, Suppl I: I-131–I-136, 1994.
57. Von Thun AM, Vari RC, El-Dahr SS, Navar LG. Augmentation of intrarenal angiotensin II levels by chronic angiotensin II infusion. Am J Physiol Renal Fluid Electrolyte Physiol 266: F120–F128, 1994.
58. Zhu XY, Chade AR, Krier JD, Daghini E, Lavi R, Guglielmotti A, Lerman A, Lerman LO. The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension. J Hypertens 27: 2063–2073, 2009.